Sientra Announces $60 Million Convertible Notes Investment from Deerfield Management
11. März 2020 16:01 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it has closed a...
Sientra to Report 4Q19 Financial Results on March 11, 2020
26. Februar 2020 16:05 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release 4Q19 financial results after the close of...
Sientra to Present at the 9th Annual SVB Leerink Global Healthcare Conference
20. Februar 2020 17:52 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 9th...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
19. Februar 2020 17:00 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on February 13, 2020, the...
Sientra Announces Preliminary Unaudited 4Q19 Net Sales and Appointment of Caroline Van Hove to Board of Directors
13. Januar 2020 07:00 ET
|
Sientra, Inc.
Anticipates total fourth quarter net sales of $23.2 million, growth of 22% year over year Aesthetics industry executive Caroline Van Hove joins Sientra’s Board of Directors SANTA BARBARA, Calif.,...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16. Dezember 2019 16:05 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on December 3, 2019, the Compensation Committee of the...
Sientra Reports Third Quarter 2019 Financial Results
07. November 2019 16:07 ET
|
Sientra, Inc.
Highlights: Record total net sales of $22.4 million in 3Q19, growth of 33% year over yearBreast Products net sales of $12.6 million in 3Q19, growth of 47% year over yearRecord miraDry net sales of...
Sientra Announces Acquisition of the Independently Operated OPUS® Breast Implant Manufacturing Operation from Lubrizol Life Science
07. November 2019 16:01 ET
|
Sientra, Inc.
Vertical integration critical next step in advancing Sientra’s strategic objectives Insourcing of breast implant supply chain provides numerous operational and financial advantages SANTA...
Sientra to Participate in Upcoming Investor Conferences
31. Oktober 2019 16:30 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that its management team will participate in the following...
Sientra to Report Third Quarter 2019 Financial Results on November 7, 2019
17. Oktober 2019 16:05 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the third quarter 2019...